PointState Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
2017
Q2
$11.6M Buy
2017
Q1
$5.75M Buy
2016
Q4
$3.62M Sell
2016
Q3
$5.27M Buy
2016
Q2
$3.4M Buy